This condition arises from a complex interplay of metabolic dysfunction and inflammatory mediators, including elevated levels of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), increased energy expenditure, and tumor-derived factors that accelerate muscle and fat wasting (3, 4). This evidence concerns the gene IL6 and neoplasm.